Vietnam Strengthens Rare Disease Management with New National Action Plan Transforming Healthcare Access and Travel Confidence for Visitors and Residents

Published on February 28, 2026

Image generated with Ai

In a landmark move, Việt Nam has spotlighted its commitment to rare disease management, bringing much-needed attention to the struggles of patients living with rare conditions. The first national ceremony marking World Rare Disease Day in Hà Nội, organised by the Medical Services Administration (MSA) under the Ministry of Health alongside the Health Economics Research and Assessment Centre, was more than a commemorative event—it was a statement that no patient will be left behind. According to latest Asia news, this initiative highlights the government’s dedication to strengthening healthcare systems for vulnerable communities across the region.

Image generated with Ai

A Historic Step in Policy and Action

This year’s ceremony coincided with the launch of the National Action Plan on Rare Disease Management 2025-2026, signaling a shift from policy discussions to tangible measures that benefit patients. Key facts shared during the event illustrate the scale of the challenge:

• Roughly six million people in Việt Nam are affected by rare diseases, which is about one in 15 citizens.
• Worldwide, over 300 million people live with approximately 6,000 different rare diseases, affecting 3.5–5.9% of the global population.
• The development of the Rare Disease List aims to streamline support policies, including access to orphan drugs.

Prof. Dr Trần Văn Thuấn, Deputy Minister of Health and Chief of the National Steering Committee for Rare Disease Management, remarked:

“This national ceremony is the clearest proof of the Vietnamese health sector’s commitment to the rare disease community. Completing the Rare Disease List and securing sustainable funding for orphan drugs are essential steps to guarantee healthcare equity for everyone.”

Advertisement

Advertisement

Turning Challenges into Solutions

Despite progress, the road ahead is not without obstacles. Discussions at the ceremony highlighted pressing issues:

• Gaps in legal frameworks and regulations surrounding rare diseases.
• Limited diagnostic capacity at provincial and district healthcare centers.
• Heavy financial burdens on families and patients.

By bringing together policymakers, healthcare professionals, and patient advocates, the event aimed to transform these challenges into actionable strategies and policies.

Concrete Measures and Initiatives

The MSA unveiled the draft Rare Disease List, a cornerstone for implementing policies to support patients. This list is critical for:

• Expanding access to orphan drugs for those in need.
• Guiding health insurance coverage and social support measures.
• Informing research priorities and funding allocations.

Other practical initiatives discussed included:

• Mobilizing community and social resources to ensure patients can access advanced therapies affordably.
• Introducing risk-sharing models for sustainable healthcare financing.
• Strengthening collaboration between public institutions, researchers, and civil society organizations.

Community Engagement and Awareness

The ceremony featured a touching handprint ritual, symbolizing solidarity with those living with rare diseases. Beyond symbolism, the event underscored the government’s push from planning to action:

• Improving diagnostic capacity to detect rare diseases early.
• Ensuring equitable access to treatments and therapies.
• Promoting healthcare equity through coordinated, patient-centered policies.

Regional and Global Perspective

Vietnam’s efforts align with international standards advocated by global health authorities. By enhancing rare disease management, the country is responding to recommendations that stress inclusivity, transparency, and patient-centered care.

Officials stressed the importance of sustained efforts, including:

• Expanding national data collection through registries and diagnostic centers.
• Training healthcare workers on identifying and treating rare diseases.
• Continuously updating policies based on healthcare outcomes and research findings.

According to latest Asia news, these measures place Việt Nam at the forefront of progressive healthcare strategies in the region, serving as a potential model for other Asian nations facing similar challenges.

A Vision for Equitable Healthcare

The National Action Plan and Rare Disease List represent a framework for providing support to millions of patients. Key actions under this framework include:

• Ensuring timely and affordable access to orphan drugs.
• Expanding insurance coverage to relieve financial stress on patients and families.
• Increasing diagnostic capacity to allow early interventions.
• Strengthening cross-sector collaboration to bolster patient support.

By implementing these measures, Việt Nam is building a healthcare system that recognizes the unique needs of rare disease patients while promoting healthcare equity across all communities.

Looking Ahead

The first national World Rare Disease Day ceremony signifies more than recognition; it marks a commitment to transforming healthcare delivery. Through the coordinated efforts of the Ministry of Health, MSA, and the National Steering Committee, Việt Nam is translating strategic plans into real-world action. With an emphasis on expanding diagnostic capacity, ensuring access to orphan drugs, and advancing rare disease management, the country is setting a standard for patient-centered healthcare.

This initiative, as highlighted in latest Asia news, underscores the government’s pledge to leave no patient behind and provides a blueprint for other nations seeking to strengthen support for rare disease communities. By fostering policies that combine financial sustainability, equity, and medical advancement, Việt Nam is lighting the path toward a healthier future for its citizens.

Key Takeaways

• Six million people in Việt Nam live with rare diseases.
• First national World Rare Disease Day held in Hà Nội.
• National Action Plan 2025-2026 launched to enhance rare disease management.
• Efforts focus on diagnostic capacity, orphan drugs, and healthcare equity.
• Collaboration between government, research institutions, and social organizations ensures patient-centered care.